Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181792 · ClinicalTrials.gov registry record
Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 70
- Enrollment target
NCT00181792: Completed study, sponsored by Massachusetts General Hospital.
NCT00181792 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181792 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The researchers will study 100 families over three years, each with a child (proband) between the ages of 12-17, with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of ADHD. The researchers hypothesize smoking will be familial and ADHD probands with a family history of tobacco use will be at increased risk for early initiation and persistence of smoking, compared to ADHD probands with no family history of tobacco use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181792
The ClinicalTrials.gov registry entry for NCT00181792 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00181792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181792 about?
NCT00181792 is a clinical study titled "Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta". The researchers will study 100 families over three years, each with a child (proband) between the ages of 12-17, with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of ADHD. The researchers hypothesize smoking will be familial and ADHD probands with a fa...
What is the current status of trial NCT00181792?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2005-05. Estimated completion is 2009-08.
Who is sponsoring clinical trial NCT00181792?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.